
OR WAIT null SECS
© 2026 MJH Life Sciences™ , Pharmaceutical Technology - Pharma News and Development Insights. All rights reserved.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
CPHI Milan, happening from October 6-8, 2026 in Milan, Italy, is expanding with 4 new zones: artificial intelligence (AI) and tech, cold chain and logistics, contamination control, and labeling.1 The show is also introducing a Sustainability Summit2 and continuing its Leadership Summit.3
The event will feature a variety of companies launching new products and services. The following are a few of those companies and what they are featuring at this year’s event.
Companies showcasing equipment and services at the event include Shilpa Biologicals (Booth 12J33), which is announcing the launch of a new gene-to-good manufacturing practice (GMP) manufacturing platform, SB HiMax. The new platform, created to accelerate development timelines, will allow biotechs to take monoclonal antibody programs from gene to clinical supply in 9 months and complex bispecific and trispecific antibodies to clinical supply in 11 months.
SB HiMax creates an integrated pathway from clone development and cell-bank creation through upstream and downstream process development, analytical-method development, GMP drug-substance manufacturing and drug-product filling. The platform has chemistry, manufacturing, and controls development and regulatory support embedded throughout and in parallel, allowing for a program to progress towards clinical studies without repeatedly transferring between different providers. It also improves yield, with the platform typically achieving >5 g/L, and scales to 2000 L while maintaining critical quality attributes and less than 10% titer variation.
“We realized the 2 biggest issues facing biotechs are: how can they expedite the process of reaching phase 1 studies, and can they get there with a cell line and process that are economical and high yielding? The challenge, of course, is that this type of solution requires a multipronged strategy, and large CDMOs [contract development manufacturing organizations] are unlikely to be able to look so prescriptively at a solution,” said Uday Harle, CEO Shilpa Biologicals, in a press release.4 “That is why we have created this new platform, enabling us to take a holistic approach so that biotechs can advance to studies more efficiently while saving precious time.”
Roquette (Booth 1A18) is showcasing its end-to-end portfolio of excipients, drug delivery solutions, and technical expertise at the event.5 Featured will be the company’s METHOCEL cellulose ethers, PEARLITOL mannitol, Avicel microcrystalline cellulose, POLYOX polyethylene oxide, KLEPTOSE cyclodextrins, LYCADEX pyrogen-free dextrose monohydrate, Qualicaps by Roquette hard capsules, and its alginate portfolio from sustainably sourced seaweed. It’s biopharma solutions for upstream processing, downstream efficiency, and formulation support will also be spotlighted.
“Pharmaceutical innovation is ultimately measured by the difference it makes in patients’ lives,” said Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business Unit, in a press release.5 “At CPHI Milan, we will show how the right combination of science, technology and partnership can turn complex formulation challenges into solutions that are more effective, reliable, and meaningful for patients.”
Systech will be offering live demonstrations of its ST16P Multi-Aggregation and Automated Label Print & Apply Station at CPHI Milan. The company announced the packaging solution, along will its new ST15S Semi-Automated Serialization and Aggregation Station on September 30, 2026.6 ST16P Multi-Aggregation and Automated Label Print & Apply Station operates with the UniSeries software and combines packaging, serialization, aggregation, and labeling functions into compact, easy-to-deploy systems, consolidating multiple processes into a single station.
“Packaging operations today are under constant pressure to increase output, maintain compliance and do more with constrained labor and facility resources,” said Steve Engdahl, vice president of Product at Systech, in a press release.6 “The ST15S and ST16P were developed to help manufacturers automate critical packaging processes and improve operational efficiency without introducing additional complexity. By bringing serialization, aggregation, rework and labeling capabilities together within integrated systems, customers can streamline workflows, reduce manual intervention and improve packaging productivity.Our product strategy begins with understanding the day-to-day challenges packaging teams face on the production floor. Those insights help us identify opportunities where automation can eliminate inefficiencies, simplify operations and improve overall packaging performance. The ST15S and ST16P reflect that customer-driven approach by delivering practical automation solutions that help manufacturers improve efficiency while remaining adaptable to changing production requirements.”
Steriline will be exhibiting its sterile filling lines at Hall 9, Stand 9A58. Featured will be the new VKSFCM11 robotic filling line, which the company says improves production efficiency by combining high process flexibility with the ‘zero-loss’ concept and full compliance with Annex 1, and the integration of state-of-the-art AI applications. The line is good for small batches and for cell and gene therapies and incorporates the new OmniAI Vision system.
“Thanks to AI, we can analyze images from the cameras positioned within the production line,” said Alessandro Caprioli, Product Development director at Steriline, in a press release.7 “These cameras, situated away from the filling, capping and crimping area, adhere to the ‘first air’ concept, provide wider fields of view and enable us to monitor a greater number of functions, offering clear benefits for our customers.”
The company’s OptiLAIN platform will also be featured. The platform is dedicated to the continuous monitoring of the overall condition of the line and predictive maintenance.
CDMO FUJIFILM Biotechnologies, which has been shortlisted for 3 CPHI Pharma Awards, will have experts presenting 3 conference sessions: Pharma’s Structural Shift: What’s Reshaping Global Priorities, Beyond the Blueprint: Executing Europe’s Bio-Manufacturing Vision, and Building a BsAb CMC Playbook: Decision Frameworks, Risks, and Readiness.
“At CPHI, I look forward to hearing directly from our partners about what they need to move their programs forward,” said Maja Pedersen, president and chief operating officer of FUJIFILM Biotechnologies, in a press release.8 “Our expanding global manufacturing network gives us more ways to support them. Our focus is on making that network work as one: kojoX. Bringing new capacity online, delivering reliably, and giving partners the visibility they need to plan with confidence.”
Click here for more of PharmTech’s coverage of CPHI Milan.